Form D · Biotechnology
Vivorte, LLC
Louisville, KY · CIK 0001476540
Offering snapshot reported Nov 12, 2009 · SEC filing
- Reported sold
- $375K Offering amount: $2M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 25, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2009 | Initial | $375,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-136009
Source: Form D, filed Nov 12, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andy Quintenz | Executive, Promoter |
| Ruth Voor | Director, Executive, Promoter |
| Michael Voor | Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1404 Oxmoor Woods Parkway
Louisville, KY, 40222
Louisville, KY, 40222